Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bron

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
Haematologica|June 10, 2017
Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modificationsEmerence Crompot, Michael Van Damme, Karlien Pieters, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2013
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, et al.
Cancers|March 8, 2019
Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological FeaturesMichele Porcu, Pushpamali De Silva, Cinzia Solinas, et al.
Plos One|August 2, 2016
Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?Yves Libert, Stéphanie Dubruille, Cindy Borghgraef, et al.
Haematologica|November 8, 2011
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatmentsBasile Stamatopoulos, Nathalie Meuleman, Cécile De Bruyn, et al.
Molecules (Basel, Switzerland)|January 20, 2021
New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death PathwaysFatima Bouhtit, Mehdi Najar, Douâa Moussa Agha, et al.
British Journal of Haematology|November 14, 2008
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cellsAmel Baya Bouzar, Mathieu Boxus, Julien Defoiche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized TrialIsabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
The Lancet. Haematology|August 2, 2016
Costs of haematological disease high and risingTony Green, Dominique Bron, Christine Chomienne, et al.
Transfusion|January 10, 2003
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignanciesMarc André, Etienne Baudoux, Dominique Bron, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Haematologica|June 10, 2017
Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modificationsEmerence Crompot, Michael Van Damme, Karlien Pieters, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2013
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, et al.
Cancers|March 8, 2019
Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological FeaturesMichele Porcu, Pushpamali De Silva, Cinzia Solinas, et al.
Plos One|August 2, 2016
Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?Yves Libert, Stéphanie Dubruille, Cindy Borghgraef, et al.
Haematologica|November 8, 2011
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatmentsBasile Stamatopoulos, Nathalie Meuleman, Cécile De Bruyn, et al.
Molecules (Basel, Switzerland)|January 20, 2021
New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death PathwaysFatima Bouhtit, Mehdi Najar, Douâa Moussa Agha, et al.
British Journal of Haematology|November 14, 2008
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cellsAmel Baya Bouzar, Mathieu Boxus, Julien Defoiche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized TrialIsabelle Demeestere, Pauline Brice, Fedro A Peccatori, et al.
The Lancet. Haematology|August 2, 2016
Costs of haematological disease high and risingTony Green, Dominique Bron, Christine Chomienne, et al.
Transfusion|January 10, 2003
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignanciesMarc André, Etienne Baudoux, Dominique Bron, et al.
Pageof 17